SOLVE FSHD Invests US$3 Million in Altay Therapeutics

VANCOUVER, B.C., Sept 21, 2022 – SOLVE FSHD, a venture-philanthropy organization catalyzing the pace of innovation to accelerate a cure for FSHD, announced today an investment of US$3 million in Altay Therapeutics; a company focused on developing lifesaving therapies by targeting disease-causing transcription factors.

This investment will support Altay Therapeutics’ unique approach to finding an inhibitor of DUX4, a key transcription factor implicated in FSHD, that could provide an effective disease modifying treatment.

A Cure is Imminent
A Cure is Imminent

The first step is clinical trials.

Partnership with SOLVE FSHD & Dr. Eva Chin
Partnership with SOLVE FSHD & Dr. Eva Chin

Dr. Eva Chin had changed the course of history for Altay Therapeutics.

Patient Community
Patient Community

What the patient community is saying.

Lab Work
Lab Work

Undruggable target's and our focus at Altay Therapeutics.

In His Own Words
In His Own Words

My life's mission has been to follow in my father's footsteps.